Efficacy Study of ABR-215050 to Treat Prostate Cancer
Public ClinicalTrials.gov record NCT00560482. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To investigate ABR-215050 as a possible treatment for prostate cancer.
Study identification
- NCT ID
- NCT00560482
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 206 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2007
- Primary completion
- May 31, 2010
- Completion
- Jul 31, 2015
- Last update posted
- Oct 25, 2015
2007 – 2015
United States locations
- U.S. sites
- 54
- U.S. states
- 17
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Clinical Research Center LLC | Anchorage | Alaska | 99508 | — |
| Southern California Permanente Medical Group | Anaheim | California | 92807 | — |
| Southern California Permanente Medical Group | Baldwin Park | California | 91706 | — |
| Southern California Permanente Medical Group | Bellflower | California | 90706 | — |
| Pacific Clinical Center | Beverly Hills | California | 90211 | — |
| South County Hematology/Oncology | Chula Vista | California | 91911 | — |
| Southern California Permanente Medical Group | Fontana | California | 92335 | — |
| Southern California Permanente Medical Group | Irvine | California | 92618 | — |
| Cancer Center Oncology Medical Group | La Mesa | California | 91942 | — |
| North County Oncology Medical Clinic, Inc. | Oceanside | California | 92056 | — |
| San Bernardino Urological Associates | San Bernardino | California | 92404 | — |
| Urological Physicians of San Diego, Inc. | San Diego | California | 92103 | — |
| Southern California Permanente Medical Group | San Diego | California | 92120 | — |
| Medical Oncology Associates - SD | San Diego | California | 92123 | — |
| Sharp Memorial Hospital Investigational Pharmacy | San Diego | California | 92123 | — |
| Sharp Rees-Stealy | San Diego | California | 92123 | — |
| Pacific Clinical Research | Santa Monica | California | 90404 | — |
| Agajanian Institute of Oncology and Hematology | Whittier | California | 90602 | — |
| Porter Adventist Hospital | Denver | Colorado | 80210 | — |
| Urology Associates, PC | Denver | Colorado | 80210 | — |
| Diagnostic Professionals, Inc | Plantation | Florida | 33317 | — |
| Southeastern Resarch Group, Inc. | Tallahassee | Florida | 32308 | — |
| Peachtree Hematology-Oncology Consultants | Atlanta | Georgia | 30309 | — |
| St. Alphonsus Regional Medical Center | Boise | Idaho | 83706 | — |
| North Idaho Urology | Coeur d'Alene | Idaho | 83814 | — |
| Idaho Urologic Institute, PA | Meridian | Idaho | 83642 | — |
| North Idaho Urology | Sandpoint | Idaho | 83864 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Evanston Northwestern Healthcare | Evanston | Illinois | 60201 | — |
| Galesburg Cottage Hospital | Galesburg | Illinois | 61401 | — |
| Medical and Surgical Specialists | Galesburg | Illinois | 61401 | — |
| OSF St Mary Medical Center | Galesburg | Illinois | 61401 | — |
| Midwest Urology/RMD Clinical Research Institute | Melrose Park | Illinois | 60160 | — |
| Johns Hopkins | Baltimore | Maryland | 21231 | — |
| AdvanceMed Research | Lawrenceville | New Jersey | 08648 | — |
| Urology Group of New Mexico | Albuquerque | New Mexico | 87109 | — |
| Community Care Physicians, PC / The Urological Institute of Northeastern New York | Albany | New York | 12208 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| University Urological Associates | New York | New York | 10016 | — |
| Staten Island Urological Research, PC | Staten Island | New York | 10304 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Wake Urological Associates | Raleigh | North Carolina | 27607 | — |
| Urologic Consultants of SE PA | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Center for Urologic Care of the Main Line | Bryn Mawr | Pennsylvania | 19010 | — |
| Urological Associates of Lancaster | Lancaster | Pennsylvania | 17604-3200 | — |
| University of Pittsburgh Physicians, Department of Urology | Pittsburgh | Pennsylvania | 15232 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232-2765 | — |
| M.D. Anderson Cancer Center | Houston | Texas | 77030 | — |
| Virginia Oncology Associates | Hampton | Virginia | 23666 | — |
| Virginia Oncology Associates | Newport News | Virginia | 23606 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Seattle Urology Research Center | Burien | Washington | 98166 | — |
| Roger D. Fincher, M.D., P.S. | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
Recently updated Prostate Cancer trials
Other public records listing Prostate Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT07796490: Neoadjuvant Intraprostatic OnabotulinumtoxinA Before Radical Prostatectomy for High-Risk Localized Prostate Cancer Not yet recruiting
- NCT07781852: Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer Not yet recruiting
- NCT00977457: Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery Active, not recruiting
- NCT04506567: Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC Active, not recruiting
- NCT07768917: Training on Systemic and Organ Spec. PM in PC Not yet recruiting
- NCT07756593: Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00560482, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00560482 live on ClinicalTrials.gov.